Table: Sapporo Clinical Lab -2020/21 div forecast
May 7 (Reuters) -
Sapporo Clinical Laboratory Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full year to Full year to
Mar 31, 2021 Mar 31, 2021
LATEST PREVIOUS
FORECAST FORECAST
Annual Div 23.00 yen 10.00 yen
-Q4 Div 23.00 yen 10.00 yen
NOTE - Sapporo Clinical Laboratory Co Ltd.
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in 2006
allowed companies to pay and report dividends on a quarterly basis.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T
Recent news on Sapporo Clinical Laboratory
See all newsTable: Sapporo Clinical Lab - 9-MTH group results
Table: Sapporo Clinical Lab - 6-MTH group results
Brief: Sapporo Clinical Laboratory Inc - To Retire Treasury Shares Worth 26% Of Outstanding Stock On Feb 17
Table: Sapporo Clinical Lab -Q1 group results
Table: Sapporo Clinical Lab -2024/25 parent results